Evaluation of the Safety and Effectiveness of the CereVasc eShunt System in the Treatment of Normal Pressure Hydrocephalus

Brief description of study

This study is evaluating the eShunt System for the treatment of patients with normal pressure hydrocephalus. The treatment is intended to reduce disability due to symptoms including one or more of gait disturbance, cognitive dysfunction and urinary incontinence.

Clinical Study Identifier: s22-00878

ClinicalTrials.gov Identifier: NCT05232838

Principal Investigator: Howard Antony Riina.

Other Investigators: William Caleb Rutledge, James B Golomb, Erez Nossek, Jeffrey H Wisoff, David H Harter.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies